OnKure Therapeutics, Inc.

NASDAQ:OKUR

Biotechnology

Healthcare
$2.82 +0.23%

+$0.01 today

Market cap
$114.22M
Beta
0.28
P/E (TTM)
-1.0
EPS (TTM)
-$4.30
52W Low $1.91High $5.38

Volume 0.17M

Average 0.37M

OKUR EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How OKUR compares with its peers on the latest reported figures

OKUR Competitors Peer median
EBITDA Margin for OKUR and competitors
Company Period LTM level YoY 3-year change
ATNMActinium Pharmaceuticals, Inc.LTM Jun 202634.7% —-33602.3 pp
XLOXilio Therapeutics, Inc.LTM Mar 2026-55.9% +527.8 pp—
OKUROnKure Therapeutics, Inc.FY2025— ——
PDSBPDS Biotechnology CorporationFY2025— ——
Peer median (excluding OKUR) -10.6%+527.8 pp-33602.3 pp

Competitors are the stored peer set for OKUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue50K000830K
Gross Profit(50K)000(830K)
Gross Margin—————
Research & Development28.12M25.86M32.12M43.8M48.26M
Selling, General & Admin11.65M3.9M4.82M10.59M14.69M
Operating Expenses39.77M29.77M36.93M54.39M62.12M
Depreciation & Amortization50K387K560K662K830K
EBITDA(39.72M)(29.13M)(34.75M)(51.71M)(58.69M)
EBITDA Margin—————
Operating Income(39.82M)(29.77M)(36.93M)(54.39M)(62.95M)
Operating Margin—————
Interest Income0254K1.62M2.01M3.44M
Interest Expense000300K0
Other Income / Expenses48K254K1.62M1.71M3.43M
Income Before Tax(39.77M)(29.51M)(35.31M)(52.67M)(59.52M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(39.77M)(29.51M)(35.31M)(52.67M)(59.52M)
Net Margin—————
EPS (Basic)(21.92)(2.21)(2.65)(3.95)(4.40)
EPS (Diluted)(21.92)(2.21)(2.65)(3.95)(4.40)
Weighted Avg Shares1.81M13.34M13.34M13.34M13.52M
Weighted Avg Shares (Diluted)1.81M13.34M13.34M13.34M13.52M

OnKure Therapeutics, Inc.

NASDAQ:OKUR

Intrinsic Alpha fair value

Locked

Current Price

$2.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.